TagsDurvalumab

Tag: durvalumab

Latest Pharma-News

Imfinzi plus chemotherapy approved in EU for patients with advanced biliary tract cancer

admin - December 21, 2022 0

Latest Pharma-News

Imfinzi plus chemotherapy improved survival benefit in advanced biliary tract cancer

admin - September 12, 2022 0

Latest Pharma-News

Imfinzi plus chemotherapy granted Priority Review in for biliary tract cancer

admin - May 4, 2022 0

Latest Pharma-News

Imfinzi plus chemotherapy reduced risk of death by 20% in 1st-line advanced biliary tract cancer

admin - January 19, 2022 0

Latest Pharma-News

AZ’s Imfinzi approved in China for extensive-stage small cell lung cancer

admin - July 19, 2021 0

Latest Pharma-News

Imfinzi approved in the EU for the treatment of lung cancer

admin - September 2, 2020 0

Most Read

What is Decentralized clinical trials?:Benefits and challenges of implementing DCT

September 23, 2024

FDA Takes Steps to Ensure Safety of Cinnamon Products Sold in the US

March 8, 2024

FDA Clears First Over-the-Counter Continuous Glucose Monitor

March 8, 2024

FDA, Industry Actions End Sales of PFAS Used in US Food Packaging

March 1, 2024

EDITOR PICKS

Job Interview Questions for Clinical Data Management 2024

August 14, 2021

CRASH COURSE ON CLINICAL DATA MANAGEMENT

November 24, 2020

Interview Questions on Institutional Review Board(IRB)

August 27, 2020

POPULAR POSTS

How to Find Paid Clinical Trials Near You

January 2, 2023

What Is CDISC and What Are CDISC Data Standards?

May 17, 2022

What is Dechallenge, Rechallenge and Prechallenge in Clinical trials?

August 5, 2021

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved